2009 | Pattern recognition analysis for the prediction of adverse effects by nonsteroidal anti-inflammatory drugs using 1H NMR-based metabolomics in rats | 이화정 | Article |
2019 | Pharmacokinetic Alteration of Paclitaxel by Ferulic Acid Derivative | 박혜영; 이화정; 이정연; 이재옥 | Article |
2019 | Pharmacokinetic Study of NADPH Oxidase Inhibitor Ewha-18278, a Pyrazole Derivative | 배윤수; 이화정; 이재옥 | Article |
2012 | Pharmacokinetic Study of NOX Inhibitor in Two Different Formulations | 이슬기 | Master's Thesis |
2019 | Pharmacokinetics and Anticancer Effect of Enteric Coated Oxaliplatin | 정다희 | Master's Thesis |
2008 | Pharmacokinetics and tissue distribution of 3-((5-(6-methylpyridin-2-yl)-4- (quinoxalin-6-yl)-1H-imidazol-2-yl)methyl)benzamide; a novel ALK5 inhibitor and a potential anti-fibrosis drug | 신윤용; 이화정; 김대기 | Article |
2019 | Pharmacokinetics and Toxicity of Heat Shock Protein 27 Inhibitor HSP-49 in Two Different Formulations | 박소현 | Master's Thesis |
2012 | Pharmacokinetics of acetaminophen and its metabolites in normal and pseudo germ-free rats | 안지혜 | Master's Thesis |
2017 | Pharmacokinetics of Heat Shock Protein 27 Inhibitor J2 in Rats | MA, LIANJI | Master's Thesis |
2017 | Pharmacokinetics of Quinolone Derivatives in Rats | 문예슬 | Master's Thesis |
2013 | Pharmacokinetics of Srx Inhibitor in Rats | 유지민 | Master's Thesis |
2023 | Pharmacokinetics study of NADPH oxidase (NOX) 2/4 inhibitor candidate, Ewha-2131 in rats | 임윤정 | Master's Thesis |
2023 | Population pharmacokinetics and model-based dosing optimization of teicoplanin in elderly critically ill patients with pneumonia | 이화정; 이정연; 이재옥 | Article |
2009 | Potent modulation of p-glycoprotein activity by naturally occurring phenylbutenoids from zingiber cassumunar | 서은경; 이화정; 한아름 | Article |
2014 | Preclinical evaluation of efficacy and stability of docetaxel micelle-encapsulated by a tripodal cyclotriphosphazene amphiphile | 손연수; 이화정 | Article |
2012 | Preclinical study of a potent P-glycoprotein and cytochrome P450 enzyme inducer rifampicin changing pharmacokinetic parameters of risperidone and its metabolite, 9-hydroxyrisperidone, using a rat model | 이화정; 이정연 | Article |
2021 | Quantification of teicoplanin using the hplc-uv method for clinical applications in critically ill patients in Korea | 이화정; 이정연; 이재옥 | Article |
2012 | Quantitative analysis of acetaminophen and its six metabolites in rat plasma using liquid chromatography/tandem mass spectrometry | 이화정 | Article |
2011 | Quantitative determination of daumone in rat plasma by liquid chromatography-mass spectrometry | 이화정; 하헌주 | Article |
2017 | Rational design, synthesis, and evaluation of novel 2,4-Chloro- and Hydroxy-Substituted diphenyl Benzofuro[3,2-b]Pyridines: Non-intercalative catalytic topoisomerase I and II dual inhibitor | 이화정; 권영주 | Article |
2018 | Regulation of endogenic metabolites by rosuvastatin in hyperlipidemia patients: An integration of metabolomics and lipidomics | 이화정 | Article |
2014 | Regulation of MRP4 mediated drug transport by NHERF3/PDZK1 in kidney | 박준희 | Doctoral Thesis |
2009 | Selective inhibition of RANK blocks osteoclast maturation and function and prevents bone loss in mice | 이수영; 이화정; 김현수 | Article |
2017 | Sensitization of lung cancer cells by altered dimerization of HSP27 | 이화정; 권영주; 이윤실 | Article |
2010 | Simple determination of azasetron in rat plasma by column-switching high-performance liquid chromatography | 이화정 | Article |
2012 | Stable and efficient delivery of docetaxel by micelle-encapsulation using a tripodal cyclotriphosphazene amphiphile | 손연수; 이화정 | Article |
2021 | Structural Requirements of 1-(2-Pyridinyl)-5-pyrazolones for Disproportionation of Boronic Acids | 배윤수; 이화정 | Article |
2004 | Study on P-glycoprotein Inhibitory Effects of Natural Compounds | 鄭守娟 | Master's Thesis |
2016 | Sulfiredoxin inhibitor induces preferential death of cancer cells through reactive oxygen species-mediated mitochondrial damage | 이화정; 정우진; 창동신 | Article |
2006 | Surface-imprinted, thermosensitive, core-shell nanosphere for molecular recognition | 이화정; 정병문 | Article |